BRUSSELS – The distribution of an preliminary 200 million doses of the COVID-19 vaccine developed by Pfizer and BioNTech throughout the European Union might be accomplished by September, a spokesman for the EU Fee stated on Monday.
The protracted timetable, which was beforehand unknown, confirms that the bloc, with a inhabitants of 450 million, will want vaccines from different suppliers to hurry up inoculations in opposition to the brand new coronavirus.
Most EU international locations started inoculating healthcare staff and susceptible folks on Sunday with the Pfizer vaccine, which is the one one to this point authorised within the 27-nation bloc, and requires a two-dose routine.
“Distribution of the complete 200 million doses is scheduled to be accomplished by September 2021,” the spokesman instructed Reuters in an emailed assertion.
He added that talks have been underway to agree the supply of an extra 100 million doses that are optionally available below the contract sealed with the 2 corporations, confirming an earlier report from Reuters.
The timetable for the extra doses is unclear.
The spokesman stated that the majority provide contracts agreed by the EU with COVID-19 vaccine makers foresee that almost all of deliveries must be accomplished by the tip of subsequent 12 months.
The EU has signed advance buy agreements with Pfizer-BioNTech, AstraZeneca, Johnson & Johnson, Moderna, Sanofi and CureVac for a complete of practically 2 billion doses.
The bloc’s drug regulator is ready to resolve on the potential approval of the Moderna vaccine on Jan. 6, and has stated that it might obtain purposes for approval from AstraZeneca and Johnson & Johnson within the first quarter of subsequent 12 months.
The EU Fee spokesman added that below a few of the agreed contracts, first deliveries might begin by March.